Drug Profile
Research programme: BAG3 protein modulators - Biouniversa
Latest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator BIOUNIVERSA
- Class
- Mechanism of Action Apoptosis regulatory protein modulators; Signal transducing adaptor protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Cancer; Cardiovascular disorders
Most Recent Events
- 13 Sep 2023 Research programme: BAG3 protein modulators is still in preclinical development for Cancer in Italy
- 13 Sep 2023 Research programme: BAG3 protein modulators is still in preclinical development for Cardiovascular-disorders in Italy
- 13 Sep 2023 Preclinical trials in Cancer (Diagnosis) in Italy (unspecified route) (before September 2023) (Biouniversa Pipeline, September 2023)